P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY

Detalles Bibliográficos
Autores principales: Manier, Salomon, Rodríguez-Otero, Paula, Mateos, Maria-Victoria, Einsele, Hermann, Bahlis, Nizar J, Munshi, Nikhil, Ailawadhi, Sikander, Arnulf, Bertrand, Nooka, Ajay, Vij, Ravi, Weum Abrahamsen, Ingerid, Broijl, Annemiek, Jagannath, Sundar, Benjamin, Reuben, Gergis, Usama, Sborov, Douglas W., Iida, Shinsuke, Truppel-Hartmann, Anna, Yang, Zhihong, Piasecki, Julia, Felten, Jasper, Caia, Andrea, Cook, Mark, Baz, Rachid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431101/
http://dx.doi.org/10.1097/01.HS9.0000970368.33859.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431101/
http://dx.doi.org/10.1097/01.HS9.0000970368.33859.48

Ejemplares similares